Search

Your search keyword '"Metzler, Markus"' showing total 707 results

Search Constraints

Start Over You searched for: Author "Metzler, Markus" Remove constraint Author: "Metzler, Markus"
707 results on '"Metzler, Markus"'

Search Results

2. Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression

4. Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients

5. Hodgkin lymphoma: hypodense lesions in mediastinal masses

6. Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trials

7. Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial

8. An artificial intelligence-assisted clinical framework to facilitate diagnostics and translational discovery in hematologic neoplasia

16. Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations

18. Model-based simulation of maintenance therapy of childhood acute lymphoblastic leukemia

19. Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding

21. Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPE

22. Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS)

24. Impact of regional SARS-CoV-2 proceedings on changes in diagnoses of pediatric malignancies in Bavaria during the COVID-19 pandemic.

27. Data mining of pediatric reference intervals

28. Human-Level Differentiation of Medulloblastoma from Pilocytic Astrocytoma: A Real-World Multicenter Pilot Study

29. CAR T-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis

30. Detection of signature double‐negative T cells is a predictive marker to identify autoimmune lymphoproliferative syndrome associated with FAS loss of function

31. Imatinib treatment and longitudinal growth in pediatric patients with chronic myeloid leukemia: Influence of demographic, pharmacological, and genetic factors in the German CML-PAED cohort

32. Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukaemia in children and young adults

33. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

34. Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group

36. Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921

37. Somatic variant profiling in chronic phase pediatric chronic myeloid leukemia

38. Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia:Results From the Phase I Part of Study ITCC054/COG AAML1921

40. Supplementary Figure S2 from Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial

41. Supplementary Data S2 from Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial

42. Supplementary Table S5 from Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial

43. Study Protocol S1 from Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial

44. Malignant teratoid tumor of the thyroid gland: an aggressive primitive multiphenotypic malignancy showing organotypical elements and frequent DICER1 alterations—is the term “thyroblastoma” more appropriate?

46. Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden

49. Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA

50. Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma

Catalog

Books, media, physical & digital resources